16:32 IST
BSE
Board Meeting Date
Mankind Pharma Board Meeting Date
Mankind Pharma will hold a board meeting on July 30, 2026. The board will consider unaudited financial results for the quarter ended June 30, 2026.
Mankind Pharma Ltd
- Share price
- ₹2,500.00
- Market cap
- ₹1,03,261 Cr
- Revenue (annual)
- ₹14,278 Cr
- Net profit (annual)
- ₹1,913 Cr
- P/E (TTM)
- 50.5×Sector 47.3×
- Promoter holding
- 72.63%-0.03% QoQ
- FII holding
- 9.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Merger & Restructuring 10Employee Stock Options 6Annual General Meeting 5Other Announcement 4Management Change 4Earnings Call 4Financial Results 3Debt & Borrowing 3Results Update 2Credit Rating 2Board Meeting Date 2Share Pledge 1Partnership 1Business Update 1Acquisition 1
Time
2 announcements with these filters
18:48 IST
BSE
Board Meeting Date
Mankind Pharma Board Meeting Date
Mankind Pharma scheduled a board meeting on May 19, 2026. Directors will approve FY26 audited results and realignment of security cover for existing NCDs.